This section hosts guidelines, manuals and toolkits to strengthen public health practice.
The World Health Organization (WHO) convened a Guideline Development Group (GDG) meeting from 29 to 31 July 2019 to review global guidance on contraceptive eligibility for women at high risk of HIV acquisition and to determine whether revisions to the fifth edition of the medical eligibility criteria for contraceptive use (MEC) were needed. This is important in offering women and adolescent girls choices to women facing high lifetime risk of acquiring HIV alongside the importance of hormonal contraception. It is also key to reducing their risk of unintended pregnancy, a common threat to the health, well-being and lives of women and adolescent girls. This guidance documents the GDG's recommendations that are based on new epidemiological evidence. It also gives several key messages for policymakers, programme managers and health-care providers to improve women's access to contraceptives. Click here to read the recommendations.